*001780072
*00520230303103542.0
*007cr
*007ta
*008140623s2004    no#           000 0 eng
*00901577cam a2200397 c 4500
*015  $a0410528$2nbf
*019  $bl
*020  $a8280800786$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)990409531144702201
*035  $a(NO-LaBS)14334509(bibid)
*035  $a(NO-TrBIB)040953114
*035  $a(NO-TrBIB)100184626
*035  $a040953114-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQV 748
*08274$a615.704$qNO-OsNB$25/nor
*1001 $aBuajordet, Ingebjørg$d1954-$0(NO-TrBIB)2093184$_105341600
*24510$aInvestigation of adverse drug events in different patient populations$cby Ingebjørg Buajordet
*260  $a[Oslo]$bDepartment of Clinical Chemistry, Ullevaal University Hospital$c2004
*300  $a1 b. (flere pag.)$bill.$c30 cm
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$vno. 159
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (doktorgrad) - Universitetet i Oslo, 2004
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2010-01-14
*588  $aKatalogisert etter omslag
*650 2$aCohort studies$_49176600
*650 2$aPharmaceutical preparations$_13842400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo (trykt utg.)$x1502-9921$vno. 159$w990122483394702201$_204428700
*85641$3Fulltekst$uhttps://urn.nb.no/URN:NBN:no-nb_digibok_2010011400026$yNettbiblioteket$zDigital representasjon
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:990409531144702202$b2021-11-14T20:49:26Z$z990409531144702202
^